xi's moments
Home | Americas

Merck has applied for emergency authorization for experimental COVID pill

chinadaily.com.cn | Updated: 2021-10-13 07:50

Merck and Ridgeback Biotherapeutics announced on Monday that they have applied to US healthcare regulators for emergency use authorization for their joint anti-coronavirus pills. A five-day course of eight pills a day, totaling 40 pills and taken orally, costs about $700.

Global Edition
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349